- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypersensitivity in Australia
Total 397 results
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Switzerland, Israel, Korea, Republic of, Japan, Poland, Argentina, Austria, Hungary
-
DBV TechnologiesRecruitingAllergy, PeanutUnited States, Canada, France, Germany, Ireland, Netherlands, Spain, United Kingdom, Australia
-
GlaxoSmithKlineCompletedAsthmaCanada, Bulgaria, Estonia, Spain, Netherlands, Germany, Australia, Austria, Belgium, Finland, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, New Zealand, United Kingdom
-
Technische Universität DresdenCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Russian Federation, Bulgaria, Canada, Chile, Peru, Philippines, South Africa, Thailand, Mexico, Israel, Ukraine, New Zealand, Croatia
-
Boehringer IngelheimPfizerCompletedAsthmaAustria, Czech Republic, Estonia, Germany, Latvia
-
AllerganCompletedAtopic ConjunctivitisCanada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, France, Germany, Poland, Romania, Russian Federation, Canada, Chile, Korea, Republic of, Ukraine, United Kingdom
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Australia, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
-
Hoffmann-La RocheCompletedAsthmaSpain, Belgium, United States, Canada, United Kingdom, France, Netherlands, Australia, New Zealand, Puerto Rico, Poland, Mexico, Slovakia, Slovenia, Czechia, Denmark
-
Biomay AGCompletedGrass Pollen AllergyAustria, Belgium, Denmark, Germany, Netherlands, Slovenia
-
Novartis PharmaceuticalsCompletedAtopic DermatitisGermany, Austria, France
-
Boehringer IngelheimPfizerCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, Russian Federation, Mexico, Australia, Ukraine
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Bulgaria, Germany, Guatemala, Hungary, Israel, Latvia, Mexico, Philippines, Portugal, South Africa, Ukraine
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
PfizerCompletedAtopic DermatitisUnited States, Canada, Australia, Germany, Hungary
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States, Canada, United Kingdom, Austria
-
GlaxoSmithKlineCompletedAsthmaUnited States, Russian Federation, Canada, Germany, Peru, Australia, Mexico, Chile, Costa Rica, Spain, Poland, Lithuania, Latvia
-
Boehringer IngelheimPfizerCompleted
-
Boehringer IngelheimCompletedAsthmaAustria, Germany, Poland, Romania, Slovakia, Slovenia
-
University of BernRecruitingCough | Asthma | Dysfunctional Breathing | Wheezing | Exercise Induced Bronchospasm | Inspiratory Laryngeal ObstructionSwitzerland, Austria
-
Boehringer IngelheimCompletedAsthmaUnited States, Australia, Canada, Colombia, Korea, Republic of, Mexico, New Zealand, Peru, Philippines, Taiwan
-
BioCryst PharmaceuticalsCompletedHereditary Angioedema (HAE)Canada, United Kingdom, Germany, Spain, Australia, Hungary, Italy, Austria, North Macedonia, Denmark, Switzerland
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
Genentech, Inc.Completed
-
PfizerAvailableAtopic DermatitisTaiwan, United States, Australia, Austria, Belgium, Canada, Greece, Mexico, Netherlands, Russian Federation, Spain, Switzerland
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
AstraZenecaTerminatedAsthmaGermany, Spain, United Kingdom, Korea, Republic of, Canada, Poland, Australia, Taiwan, Hungary, Ukraine
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Germany, Guatemala, Hungary, Latvia, Lithuania, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaMexico, Spain, Argentina, Japan, Poland, United States, Turkey, Australia, Brazil, Canada, Chile, Colombia, Hungary, Italy, Lithuania, Russian Federation, South Africa, Ukraine
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, United Kingdom, Czechia, Mexico, Italy
-
Novartis PharmaceuticalsCompletedChronic Myelomonocytic Leukemia | Hypereosinophilic Syndrome | Systemic Mastocytosis | DermatofibrosarcomaAustralia
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Finland, Germany, Japan, Netherlands, Spain
-
AstraZenecaCompletedAsthmaHungary, South Africa, Poland, Spain, Canada, Australia, Czech Republic
-
AstraZenecaCompletedAsthmaFrance, United Kingdom, Korea, Republic of, Argentina, Australia, Spain, Colombia
-
GlaxoSmithKlineIqvia Pty LtdRecruitingAsthmaUnited States, Australia, Canada, France, Germany, Italy, Japan, Poland, Spain, China, Czechia, Hungary, Taiwan, United Kingdom
-
Intellia TherapeuticsActive, not recruitingHereditary AngioedemaFrance, New Zealand, Germany, United Kingdom, Netherlands, Australia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Czechia, Italy, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Poland, Romania, Russian Federation, Mexico, Ukraine, Australia, Philippines
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | AsthmaUnited States, Slovakia, India, Malaysia, Australia, Former Serbia and Montenegro
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingAsthmaUnited States, Japan, Poland, Spain, Italy, Australia, Taiwan, France, Hungary, Canada, Czechia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Bulgaria, Canada, Chile, France, Peru, Russian Federation, South Africa, Mexico, Estonia, Netherlands, Thailand, Poland, Czechia
-
AstraZenecaCompletedAsthmaBrazil, France, South Africa, Spain, Vietnam, Germany, Philippines, Malaysia, China, Canada, Argentina, Australia, Mexico, Thailand, Indonesia, Singapore, India
-
AstraZenecaCompletedAsthmaGermany, South Africa, Austria, Canada, Poland
-
AstraZenecaPfizerCompletedAsthmaUnited States, Austria, Croatia, Czech Republic, Finland, France, Greece, Hungary, India, Ireland, Italy, New Zealand, Norway, Pakistan, Philippines, Poland, Portugal, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thai... and more
-
Bristol-Myers SquibbCompletedDermatitis, AtopicGermany, Australia, Poland, Canada, Austria, United States, Spain
-
AmgenAstraZeneca; Kyowa Kirin Co., Ltd.TerminatedAsthmaUnited States, Canada, France, Germany, Italy, Taiwan, Hong Kong, Australia, Greece, Russian Federation, Poland, Ireland, Puerto Rico, Korea, Republic of, New Zealand
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand